Lin Yang
Mayo Clinic(US)China Pharmaceutical University(CN)First Affiliated Hospital of Hunan University of Traditional Chinese Medicine(CN)Mayo Clinic in Florida(US)
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Ion channel regulation and function, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, MicroRNA in disease regulation
Most-Cited Works
- → An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity inPten+/−mice(2001)571 cited
- → Mechanism of adrenergic CaV1.2 stimulation revealed by proximity proteomics(2020)242 cited
- → Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel(2007)203 cited
- → Protein Kinase G Phosphorylates Cav1.2 α1cand β2Subunits(2007)108 cited
- → Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways(2006)98 cited
- → Tocilizumab mimotope alleviates kidney injury and fibrosis by inhibiting IL-6 signaling and ferroptosis in UUO model